1. Home
  2. SMG vs KNSA Comparison

SMG vs KNSA Comparison

Compare SMG & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scotts Miracle-Gro Company (The)

SMG

Scotts Miracle-Gro Company (The)

HOLD

Current Price

$62.56

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$45.79

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMG
KNSA
Founded
1868
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
SMG
KNSA
Price
$62.56
$45.79
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$73.00
$55.29
AVG Volume (30 Days)
913.3K
514.2K
Earning Date
04-29-2026
04-28-2026
Dividend Yield
4.26%
N/A
EPS Growth
504.92
225.00
EPS
N/A
0.75
Revenue
$3,016,500,000.00
$677,564,000.00
Revenue This Year
N/A
$37.60
Revenue Next Year
$2.63
$17.77
P/E Ratio
N/A
$62.51
Revenue Growth
6.17
60.09
52 Week Low
$45.61
$19.62
52 Week High
$72.35
$50.03

Technical Indicators

Market Signals
Indicator
SMG
KNSA
Relative Strength Index (RSI) 48.24 45.17
Support Level $58.68 $44.36
Resistance Level $64.96 $46.93
Average True Range (ATR) 2.58 1.96
MACD 0.05 -0.22
Stochastic Oscillator 50.14 23.45

Price Performance

Historical Comparison
SMG
KNSA

About SMG Scotts Miracle-Gro Company (The)

Scotts Miracle-Gro is the largest purveyor of home lawn and gardening products in the US. The company sells a broad range of lawncare products, including grass seed, fertilizer, and lawn-related weed, animal, and disease control. US consumer typically generates the vast majority of companywide revenue and profits. Its lawncare and gardening products are well-recognized brands in the US, including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: